- Home
- PYPD vs GYRO Comparison
PYPD vs GYRO Comparison
Compare PYPD & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- GYRO
- Stock Information
- Founded
- PYPD 2008
- GYRO 1946
- Country
- PYPD Israel
- GYRO United States
- Employees
- PYPD N/A
- GYRO N/A
- Industry
- PYPD Medical/Dental Instruments
- GYRO Building operators
- Sector
- PYPD Health Care
- GYRO Real Estate
- Exchange
- PYPD Nasdaq
- GYRO Nasdaq
- Market Cap
- PYPD 16.5M
- GYRO 19.2M
- IPO Year
- PYPD 2020
- GYRO N/A
- Fundamental
- Price
- PYPD $2.93
- GYRO $9.30
- Analyst Decision
- PYPD Strong Buy
- GYRO
- Analyst Count
- PYPD 2
- GYRO 0
- Target Price
- PYPD $12.00
- GYRO N/A
- AVG Volume (30 Days)
- PYPD 28.7K
- GYRO 1.4K
- Earning Date
- PYPD 02-12-2025
- GYRO 01-01-0001
- Dividend Yield
- PYPD N/A
- GYRO N/A
- EPS Growth
- PYPD N/A
- GYRO N/A
- EPS
- PYPD N/A
- GYRO N/A
- Revenue
- PYPD N/A
- GYRO $2,738,019.00
- Revenue This Year
- PYPD N/A
- GYRO N/A
- Revenue Next Year
- PYPD N/A
- GYRO N/A
- P/E Ratio
- PYPD N/A
- GYRO N/A
- Revenue Growth
- PYPD N/A
- GYRO N/A
- 52 Week Low
- PYPD $2.37
- GYRO $7.65
- 52 Week High
- PYPD $9.20
- GYRO $11.96
- Technical
- Relative Strength Index (RSI)
- PYPD 33.37
- GYRO 44.98
- Support Level
- PYPD $2.37
- GYRO $8.77
- Resistance Level
- PYPD $3.13
- GYRO $9.40
- Average True Range (ATR)
- PYPD 0.24
- GYRO 0.08
- MACD
- PYPD -0.06
- GYRO -0.00
- Stochastic Oscillator
- PYPD 19.30
- GYRO 46.09
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About GYRO Gyrodyne LLC
Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.